Concepts (178)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fertilization in Vitro | 11 | 1998 | 12 | 0.630 |
Why?
|
| Chorionic Gonadotropin | 12 | 1995 | 15 | 0.580 |
Why?
|
| Menotropins | 10 | 1996 | 10 | 0.480 |
Why?
|
| Estradiol | 12 | 1998 | 58 | 0.430 |
Why?
|
| Pregnancy | 16 | 1997 | 403 | 0.380 |
Why?
|
| Fallopian Tubes | 5 | 1997 | 7 | 0.360 |
Why?
|
| Ovulation Induction | 9 | 1996 | 9 | 0.350 |
Why?
|
| Infertility, Female | 8 | 1999 | 19 | 0.350 |
Why?
|
| Embryo Transfer | 3 | 1995 | 3 | 0.290 |
Why?
|
| Uterus | 2 | 1997 | 15 | 0.280 |
Why?
|
| Gonadotropin-Releasing Hormone | 4 | 1995 | 7 | 0.260 |
Why?
|
| Abortion, Spontaneous | 4 | 1995 | 9 | 0.260 |
Why?
|
| Sperm Motility | 2 | 1994 | 5 | 0.240 |
Why?
|
| Endometriosis | 8 | 1994 | 13 | 0.240 |
Why?
|
| Progesterone | 10 | 1995 | 26 | 0.230 |
Why?
|
| Hyperprolactinemia | 2 | 1995 | 3 | 0.210 |
Why?
|
| Ovarian Follicle | 4 | 1998 | 7 | 0.210 |
Why?
|
| Pregnancy, Multiple | 3 | 1991 | 4 | 0.200 |
Why?
|
| Female | 38 | 2021 | 16197 | 0.190 |
Why?
|
| Fertilization | 4 | 1994 | 5 | 0.190 |
Why?
|
| Prospective Studies | 13 | 1998 | 1811 | 0.180 |
Why?
|
| Embryo, Mammalian | 3 | 1997 | 31 | 0.180 |
Why?
|
| Luteal Phase | 3 | 1995 | 6 | 0.180 |
Why?
|
| Pregnancy Outcome | 3 | 1995 | 20 | 0.170 |
Why?
|
| Independent Living | 1 | 2021 | 281 | 0.170 |
Why?
|
| Zona Pellucida | 1 | 1997 | 1 | 0.160 |
Why?
|
| Sperm Count | 2 | 1994 | 5 | 0.160 |
Why?
|
| Ultrasonography | 3 | 1996 | 226 | 0.150 |
Why?
|
| Pregnancy, Ectopic | 2 | 1994 | 2 | 0.150 |
Why?
|
| Quality of Life | 1 | 2021 | 662 | 0.140 |
Why?
|
| Gamete Intrafallopian Transfer | 2 | 1995 | 2 | 0.140 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1996 | 10 | 0.140 |
Why?
|
| Hormones | 4 | 1993 | 13 | 0.140 |
Why?
|
| Humans | 38 | 2021 | 29337 | 0.140 |
Why?
|
| Chromosome Aberrations | 2 | 1993 | 15 | 0.140 |
Why?
|
| Bacteria | 1 | 1995 | 77 | 0.130 |
Why?
|
| Biopsy, Needle | 1 | 1995 | 101 | 0.130 |
Why?
|
| Bacterial Infections | 1 | 1995 | 69 | 0.130 |
Why?
|
| Monitoring, Physiologic | 1 | 1996 | 92 | 0.130 |
Why?
|
| Hysterosalpingography | 1 | 1994 | 2 | 0.130 |
Why?
|
| Insemination, Artificial, Homologous | 1 | 1994 | 1 | 0.130 |
Why?
|
| Endometrium | 2 | 1996 | 7 | 0.130 |
Why?
|
| Adult | 21 | 2001 | 8601 | 0.120 |
Why?
|
| Granulosa Cells | 3 | 2001 | 4 | 0.120 |
Why?
|
| Blastocyst | 4 | 1997 | 5 | 0.120 |
Why?
|
| Acrosin | 1 | 1993 | 1 | 0.120 |
Why?
|
| Semen | 1 | 1993 | 5 | 0.110 |
Why?
|
| Spermatozoa | 1 | 1993 | 10 | 0.110 |
Why?
|
| Fertility | 1 | 1993 | 20 | 0.110 |
Why?
|
| Pregnadienes | 5 | 1989 | 5 | 0.100 |
Why?
|
| Danazol | 5 | 1989 | 6 | 0.100 |
Why?
|
| Fetal Resorption | 1 | 1991 | 1 | 0.100 |
Why?
|
| Twins | 1 | 1991 | 8 | 0.100 |
Why?
|
| Follicle Stimulating Hormone | 4 | 2001 | 24 | 0.100 |
Why?
|
| Follicular Fluid | 4 | 2001 | 4 | 0.090 |
Why?
|
| Ovary | 3 | 1999 | 17 | 0.090 |
Why?
|
| Pregnancy Trimester, First | 4 | 1993 | 9 | 0.080 |
Why?
|
| Embryonic and Fetal Development | 3 | 1996 | 8 | 0.080 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 1988 | 3 | 0.080 |
Why?
|
| Infertility | 1 | 1987 | 6 | 0.080 |
Why?
|
| Prolactin | 1 | 1987 | 3 | 0.080 |
Why?
|
| Mice | 4 | 1997 | 1607 | 0.070 |
Why?
|
| Leuprolide | 4 | 1995 | 7 | 0.070 |
Why?
|
| Vagina | 2 | 1995 | 46 | 0.060 |
Why?
|
| Sleep | 1 | 1987 | 313 | 0.060 |
Why?
|
| Autoantibodies | 2 | 1999 | 100 | 0.060 |
Why?
|
| Oocytes | 2 | 1997 | 16 | 0.060 |
Why?
|
| Male | 6 | 2021 | 15621 | 0.060 |
Why?
|
| Ovarian Hyperstimulation Syndrome | 2 | 1992 | 2 | 0.060 |
Why?
|
| Culture Media | 3 | 1996 | 38 | 0.050 |
Why?
|
| Poland | 1 | 2021 | 6 | 0.050 |
Why?
|
| Receptors, Gonadotropin | 1 | 2001 | 1 | 0.050 |
Why?
|
| Time Factors | 2 | 1997 | 1616 | 0.050 |
Why?
|
| Physical Fitness | 1 | 2021 | 59 | 0.050 |
Why?
|
| Ovulation | 2 | 1991 | 2 | 0.050 |
Why?
|
| Animals | 6 | 2001 | 4552 | 0.050 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 1999 | 6 | 0.040 |
Why?
|
| Pelvic Neoplasms | 2 | 1989 | 7 | 0.040 |
Why?
|
| Menopause, Premature | 1 | 1999 | 7 | 0.040 |
Why?
|
| Coculture Techniques | 2 | 1996 | 37 | 0.040 |
Why?
|
| Buserelin | 2 | 1989 | 2 | 0.040 |
Why?
|
| Luteal Cells | 1 | 1998 | 2 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 959 | 0.040 |
Why?
|
| Calmodulin | 1 | 1997 | 11 | 0.040 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 2 | 1987 | 2 | 0.040 |
Why?
|
| Sulfonamides | 1 | 1997 | 54 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 1997 | 213 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 1997 | 145 | 0.040 |
Why?
|
| Cytological Techniques | 1 | 1996 | 14 | 0.040 |
Why?
|
| Imidazoles | 1 | 1997 | 72 | 0.040 |
Why?
|
| Peptide Fragments | 2 | 1987 | 99 | 0.040 |
Why?
|
| Prognosis | 4 | 1993 | 840 | 0.040 |
Why?
|
| Pregnancy Rate | 1 | 1995 | 1 | 0.030 |
Why?
|
| Pelvic Inflammatory Disease | 1 | 1995 | 2 | 0.030 |
Why?
|
| Ascitic Fluid | 1 | 1995 | 10 | 0.030 |
Why?
|
| Karyotyping | 2 | 1993 | 13 | 0.030 |
Why?
|
| Follicular Phase | 1 | 1995 | 3 | 0.030 |
Why?
|
| Culture Techniques | 1 | 1995 | 26 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 1995 | 65 | 0.030 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 1 | 1994 | 2 | 0.030 |
Why?
|
| Life Tables | 1 | 1994 | 5 | 0.030 |
Why?
|
| Catheterization | 1 | 1994 | 51 | 0.030 |
Why?
|
| Methotrexate | 1 | 1994 | 41 | 0.030 |
Why?
|
| Clomiphene | 3 | 1988 | 5 | 0.030 |
Why?
|
| Embryo Implantation | 2 | 1990 | 2 | 0.030 |
Why?
|
| Menstrual Cycle | 2 | 1990 | 27 | 0.030 |
Why?
|
| Maternal Age | 1 | 1993 | 15 | 0.030 |
Why?
|
| Chromosome Disorders | 1 | 1993 | 20 | 0.030 |
Why?
|
| Incidence | 1 | 1995 | 756 | 0.030 |
Why?
|
| Biopsy | 1 | 1993 | 234 | 0.030 |
Why?
|
| Random Allocation | 4 | 1999 | 146 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 4851 | 0.030 |
Why?
|
| Cohort Studies | 1 | 1997 | 1939 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 1 | 1991 | 22 | 0.030 |
Why?
|
| Oligomenorrhea | 1 | 1991 | 2 | 0.020 |
Why?
|
| Pituitary Hormone-Releasing Hormones | 1 | 1988 | 1 | 0.020 |
Why?
|
| Laparoscopy | 2 | 1989 | 145 | 0.020 |
Why?
|
| Zygote | 1 | 1988 | 2 | 0.020 |
Why?
|
| Preservation, Biological | 1 | 1988 | 5 | 0.020 |
Why?
|
| Minerals | 1 | 1988 | 6 | 0.020 |
Why?
|
| Ovarian Cysts | 1 | 1988 | 5 | 0.020 |
Why?
|
| Microsurgery | 1 | 1988 | 40 | 0.020 |
Why?
|
| Aged | 1 | 2021 | 9448 | 0.020 |
Why?
|
| Bone and Bones | 1 | 1988 | 119 | 0.020 |
Why?
|
| Ovarian Diseases | 1 | 1986 | 2 | 0.020 |
Why?
|
| Fertility Agents | 1 | 1986 | 1 | 0.020 |
Why?
|
| Mice, Inbred Strains | 2 | 1996 | 28 | 0.020 |
Why?
|
| Cell Count | 2 | 1996 | 99 | 0.020 |
Why?
|
| Luteinizing Hormone | 3 | 1989 | 12 | 0.020 |
Why?
|
| Receptors, LH | 1 | 2001 | 1 | 0.010 |
Why?
|
| CHO Cells | 1 | 2001 | 12 | 0.010 |
Why?
|
| Cricetinae | 1 | 2001 | 36 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2001 | 198 | 0.010 |
Why?
|
| Cardiolipins | 1 | 1999 | 1 | 0.010 |
Why?
|
| Antigens, Nuclear | 1 | 1999 | 2 | 0.010 |
Why?
|
| Blood Donors | 1 | 1999 | 6 | 0.010 |
Why?
|
| Causality | 1 | 1999 | 53 | 0.010 |
Why?
|
| Thyroid Gland | 1 | 1999 | 27 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 1999 | 88 | 0.010 |
Why?
|
| Mitotic Index | 1 | 1998 | 4 | 0.010 |
Why?
|
| Cell Division | 1 | 1998 | 113 | 0.010 |
Why?
|
| Spindle Apparatus | 1 | 1997 | 1 | 0.010 |
Why?
|
| Adenine | 1 | 1997 | 5 | 0.010 |
Why?
|
| Chromatin | 1 | 1997 | 15 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1997 | 21 | 0.010 |
Why?
|
| Paclitaxel | 1 | 1997 | 74 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 1997 | 85 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 1997 | 47 | 0.010 |
Why?
|
| Rabbits | 1 | 1997 | 280 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1997 | 437 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1996 | 148 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 1997 | 391 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 1996 | 44 | 0.010 |
Why?
|
| Cell Line | 1 | 1996 | 298 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 1996 | 145 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 1996 | 87 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 1995 | 22 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1995 | 56 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 1995 | 78 | 0.010 |
Why?
|
| CA-125 Antigen | 1 | 1994 | 3 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 1994 | 37 | 0.010 |
Why?
|
| Glycoproteins | 1 | 1994 | 58 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 1994 | 521 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 1994 | 638 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1992 | 676 | 0.010 |
Why?
|
| Menstruation | 1 | 1989 | 5 | 0.010 |
Why?
|
| Administration, Intranasal | 1 | 1989 | 26 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 1988 | 7 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 1988 | 28 | 0.010 |
Why?
|
| Antibody Formation | 1 | 1988 | 40 | 0.010 |
Why?
|
| Body Weight | 1 | 1989 | 133 | 0.010 |
Why?
|
| Amenorrhea | 1 | 1988 | 2 | 0.010 |
Why?
|
| Freezing | 1 | 1988 | 14 | 0.010 |
Why?
|
| Syndrome | 1 | 1988 | 82 | 0.000 |
Why?
|
| Anovulation | 1 | 1986 | 1 | 0.000 |
Why?
|
| Recurrence | 1 | 1988 | 350 | 0.000 |
Why?
|
| Risk Factors | 1 | 1992 | 2443 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 1992 | 3273 | 0.000 |
Why?
|